High-flow Nasal Cannula Market

High-flow Nasal Cannula Market Outlook (2023 to 2033)

Global sales of high-flow nasal cannulas are estimated to increase at a prolific CAGR of 12% from 2023 to 2033. The market is valued at US$ 7.7 billion in 2023 and is thus expected to reach US$ 24 billion by 2033-end.

Hospitals are preferred by patients suffering from chronic obstructive pulmonary diseases due to their advanced healthcare facilities. High-flow nasal cannulas are widely used in hospitals to provide respiratory treatments because they provide benefits such as the reduced risk of infection and an ideal flow rate.

An oxygen delivery system called a high-flow nasal cannula can deliver up to 100% heated, humidified oxygen at a flow rate of up to 60 liters per minute. High-flow nasal cannulas are gaining popularity as alternate respiratory support for seriously ill patients.

High-flow nasal cannulas are effective for treating hypercapnic respiratory failure and mild to severe hypoxemic respiratory failure, in addition to respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). The increasing prevalence of asthma and COPD worldwide as well as the growing elderly population are the elements driving market expansion.

Smoking prevalence and air pollution levels have been rising globally in recent years, in both developed and developing countries. Asthma causes the airways to swell, become more constricted, and produce mucus. Wheezing, coughing, and repeated episodes of breathlessness are other consequences of this, and the degree and regularity of these episodes vary from person to person. It is estimated that 235 million people worldwide have asthma, according to the World Health Organization.

Shortness of breath, chest tightness, a persistent cough, respiratory infections, wheezing, and other symptoms are all long-term effects of chronic obstructive pulmonary disease, a lung disease. The market for high-flow nasal cannulas is expanding as a result of factors such as the rising prevalence of lung cancer as well as the rising demand for heated humidified high-flow nasal cannulas.

Additionally, one of the reasons driving the market growth is corporate investments in R&D initiatives that aim to develop better goods and more advanced technology. The market is expanding as a result of the expanding popularity of oxygen therapy and the advancement of developing new techniques.

Market share is expected to increase due to the special benefits of high-flow nasal cannulas and the patients' increasing acceptance of this treatment approach. During the projection period, it is also anticipated that the market for high-flow nasal cannulas would grow due to the increasing prevalence of sleep apnea. In clinical practice, high-flow oxygen therapy (HFOT) delivered using a nasal cannula has been shown to be safe and beneficial in providing respiratory support with acceptable airway humidity.

Report Attributes	Details
High-flow Nasal Cannula Market Size (2023)	US$ 7.7 Billion
Projected Market Value (2033)	US$ 24 Billion
Global Market Growth Rate (2023 to 2033)	12% CAGR
Market Share of Nasal Cannulas	60%
Key Companies Profiled	Hamilton Medical; ResMed Inc.; TNI Medical AG; Teleflex; Salter Labs Inc.; Vapotherm Inc.; Smiths Medical, Inc.

Why are Sales of High-flow Nasal Cannulas Surging across the World?

“Growing Geriatric Population Driving Global Demand for High-flow Nasal Cannulas”

The elderly population is especially prone to many respiratory illnesses. As a result, the expansion of the worldwide high-flow nasal cannula market will be aided by the expanding geriatric population.

Asthma and COPD are more common among the elderly than the younger population, and their effects on quality of life are particularly severe. As the senior population expands, so will the incidence of COPD and asthma. In addition, there will be an increase in hospital admissions and treatments. Considering that older people widely utilize high-flow nasal cannula products for respiratory care, this will lead to a rise in demand for these products.

“Constant Innovations in High-flow Nasal Cannula Systems”

Technological advancements by key market players are also anticipated to boost the market. Moreover, clinical trials for evaluating new application areas shall open up new avenues for the market.

Innovative high-flow nasal cannula products that are safer and more convenient to use than conventional devices have been made available due to new developments in technology. With more patients throughout the world adopting this, the market is growing faster.

High-velocity nasal insufflation systems and the creation of a single-use patient interface for high-flow oxygen treatment delivery in hospital settings are two significant industry advances. The benefits connected to high-flow nasal cannulas such as the assistance these devices offer in reducing breathing frequency and work of breathing and the reduction of the necessity of respiratory support escalation have put the market towards a positive growth outlook over the coming years.

Which Obstacles Should High-flow Nasal Cannula Producers Overcome?

“High Price of High-flow Nasal Cannulas and Availability of Substitutes”

There are several risks to take into account before using any form of additional oxygen. Long-term use has been linked to respiratory issues, eye impairment, and pulmonary oxygen toxicity, which happens when the body receives too much oxygen and can harm the lungs. The high price of high-flow nasal cannulas compared to standard oxygen cannulas and increased complexity could impede market expansion, according to pricing trends.

There are numerous alternative options on the market, which are expected to restrain the growth of the nasal cannula market over the forecast period. For instance, the market may be hampered by the availability of solutions such as full-face masks and complete masks with tubing that can be utilized to give oxygen to the patient.

Why is Demand for High-flow Nasal Cannulas High in North America?

“Growing Preference for Non-invasive Ventilation”

North America accounts for over 50% share of the total market value. Growing preference for non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) devices has augmented rapidly in home care settings for patients suffering from respiratory diseases in North America. This has stimulated key manufacturers to increase the production of high-flow nasal cannula devices, thus increasing the market share.

Country-wise Insights

Why is the United States Commanding the North American Market?

“Advancements in Nasal Cannula Treatments across the Country”

The market in the United States is anticipated to have many potential prospects due to the advancements in nasal cannula treatments. Market growth is attributed to many factors, including the presence of well-established healthcare facilities, an increase in the local supply of air humidifiers, and growing public awareness of advanced medical technologies.

Why are Manufacturers of High-flow Nasal Cannulas Earning More Profits in Germany?

“Rising Prevalence of Premature Births in the Country”

Germany shows impressive growth prospects for the high-flow nasal cannula market during the forecast period. The rising prevalence of premature births is anticipated to fuel the market growth over the forecast period. An increase in investments by government organizations for the treatment of such respiratory illnesses and expanding R&D efforts are driving market growth in Germany.

Why is Japan a Prominent Market for High-flow Nasal Cannulas?

“Favorable Healthcare & Reimbursement Policies in Japan”

The market in Japan is projected to expand at a CAGR of 11% over the forecast period. The increasing population, degraded air quality, and growing smoking prevalence have increased the prevalence of respiratory disease cases. The presence of top market participants and rising healthcare expenditure, favorable healthcare and reimbursement policies, and improving healthcare standards are supporting market expansion.

Category-wise Insights

Which Component is Projected to Account for Substantial Revenue Generation?

“Nasal Cannulas Widely Used for Providing Respiratory Supportive Care with Appropriate Airway Humidity”

Based on component, the market is divided into air/oxygen blenders, air humidifiers, single heated tubes, nasal cannulas, and others. Nasal cannulas account for 60% share of the global market owing to the rising prevalence of respiratory diseases.

An individual who is unable to obtain enough oxygen for sustained normal body function is given oxygen via a nasal cannula. A flexible plastic tube called a nasal cannula has two tiny prongs that slide into the nostrils. It is utilized to provide a patient with a high flow of oxygen. The prongs are attached to a tank or wall outlet that provides oxygen. A flow meter on the oxygen supply controls the flow of oxygen.

A patient receives more oxygen from high-flow nasal cannulas than from a conventional cannula. This can be advantageous for those who require more oxygen to maintain their health, such as those with chronic respiratory diseases such as COPD or asthma.

Which Application is Likely to Contribute the Most to Market Expansion?

“High-flow Nasal Cannulas Preferred for Acute Respiratory Failure Treatment”

Based on the application, the market is classified into acute respiratory failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, bronchiectasis, sleep apnea, and others. The use of high-flow nasal cannulas in acute respiratory failure treatment is increasing due to their unique advantages and the growing acceptance of these devices among patients suffering from acute respiratory disorders.

Moreover, high-flow nasal cannula devices can also help in sleep apnea treatment by delivering a consistent flow of oxygen via the nasal cannula and alleviating upper airway obstruction. The rising prevalence of sleep apnea is also anticipated to boost the market of high-flow nasal cannulas.

Competitive Landscape

Top high-flow nasal cannula providers are consistently innovating their product portfolios through technological advancements to acquire market presence. Key market players are making high investments in R&D projects to enhance quality control of products using advanced technologies and following safety regulations to reduce the environmental impact.

Major high-flow nasal cannula manufacturers are focusing on producing top-notch cannulas and distributing them to clinics, hospitals, and healthcare institutions. Leading companies in the high-flow nasal cannula market use a variety of strategies to boost sales across numerous geographies, including improving product standards, collaborations, and supply chain management.

For instance,

• Fisher & Paykel Healthcare is a leading player in the global high-flow nasal cannula market. Its flagship products include F&P 950 Humidifier, Optiflow High-flow System, and the AIRVO 2. Other products include OptiFlowTM Nasal High, F&P Brevida Masks, and the F&P SimplusTM Full Face Masks.
• ResMed Inc. is another market leader in the respiratory therapy market. It offers a strong product portfolio for the treatment of sleep apnea and non-invasive ventilation. Its flagship products include AirView, myAir, and ClimateLine MAX for the treatment and management of sleep apnea and respiratory disorders.
• In August 2021, ResMed introduced AirSense 11, its newest positive airway pressure (PAP) device for treating and controlling obstructive sleep apnea.

Key Segments of High-Flow Nasal Cannula Industry Research

• By Component :

  • Air/Oxygen Blenders
  • Air Humidifiers
  • Single Heated Tubes
  • Nasal Cannulas
  • Others

• By Application :

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Carbon Monoxide Toxicity
  • Bronchiectasis
  • Sleep Apnea
  • Others

• By End User :

  • Hospitals
  • Long-term Care Centers
  • Ambulatory Care Centers
  • Others

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa